Jessica L Reed

Ketamine normalizes brain activity during emotionally valenced attentional processing in depression.

NeuroImage: Clinical 2018 Jessica L Reed, Allison C. Nugent, Maura L. Furey et al.

An urgent need exists for faster-acting pharmacological treatments in major depressive disorder (MDD). The glutamatergic modulator ketamine has been shown to have rapid antidepressant effects, but much remains unknown about its mechanism of action. Functional MRI (fMRI) can be used to investigate how ketamine impacts brain activity during cognitive and emotional processing. This double-blind,...